AAAAAA

   
Results: 1-25 | 26-42 |
Results: 26-42/42
In vitro characterization of five humanized OKT3 effector function variantantibodies
Authors: Xu, DL Alegre, ML Varga, SS Rothermel, AL Collins, AM Pulito, VL Hanna, LS Dolan, KP Parren, PWHI Bluestone, JA Jolliffe, LK Zivin, RA
Citation: Dl. Xu et al., In vitro characterization of five humanized OKT3 effector function variantantibodies, CELL IMMUN, 200(1), 2000, pp. 16-26
The CTLA-4 gene is expressed in placental fibroblasts
Authors: Kaufman, KA Bowen, JA Tsai, AF Bluestone, JA Hunt, JS Ober, C
Citation: Ka. Kaufman et al., The CTLA-4 gene is expressed in placental fibroblasts, MOL HUM REP, 5(1), 1999, pp. 84-87
TCR gamma delta cells and viruses
Authors: Sciammas, R Bluestone, JA
Citation: R. Sciammas et Ja. Bluestone, TCR gamma delta cells and viruses, MICROBES IN, 1(3), 1999, pp. 203-212
CD28 interactions with either CD80 or CD86 are sufficient to induce allergic airway inflammation in mice
Authors: Mathur, M Herrmann, K Qin, YM Gulmen, F Li, XT Krimins, R Weinstock, J Elliott, D Bluestone, JA Padrid, P
Citation: M. Mathur et al., CD28 interactions with either CD80 or CD86 are sufficient to induce allergic airway inflammation in mice, AM J RESP C, 21(4), 1999, pp. 498-509
Phase I trial of a humanized, fc receptor nonbinding OKT3 antibody, huOKT3gamma(1)(Ala-Ala) in the treatment of acute renal allograft rejection
Authors: Woodle, ES Xu, DL Zivin, RA Auger, J Charette, J O'Laughlin, R Peace, D Jolliffe, LK Haverty, T Bluestone, JA Thistlethwaite, JR
Citation: Es. Woodle et al., Phase I trial of a humanized, fc receptor nonbinding OKT3 antibody, huOKT3gamma(1)(Ala-Ala) in the treatment of acute renal allograft rejection, TRANSPLANT, 68(5), 1999, pp. 608-616
Induction, maintenance, and reversal of streptozotocin-induced insulin-dependent diabetes mellitus in the juvenile cynomolgus monkey (Macaca fascilularis)
Authors: Theriault, BR Thistlethwaite, JR Levisetti, MG Wardrip, CL Szot, G Bruce, DS Rilo, H Li, XT Gray, GS Bluestone, JA Padrid, PA
Citation: Br. Theriault et al., Induction, maintenance, and reversal of streptozotocin-induced insulin-dependent diabetes mellitus in the juvenile cynomolgus monkey (Macaca fascilularis), TRANSPLANT, 68(3), 1999, pp. 331-337
Cutting edge: Blockade of the CD28/B7 costimulatory pathway inhibits intestinal allograft rejection mediated by CD4(+) but not CD8(+) T cells
Authors: Newell, KA He, G Guo, Z Kim, O Szot, GL Rulifson, I Zhou, P Hart, J Thistlethwaite, JR Bluestone, JA
Citation: Ka. Newell et al., Cutting edge: Blockade of the CD28/B7 costimulatory pathway inhibits intestinal allograft rejection mediated by CD4(+) but not CD8(+) T cells, J IMMUNOL, 163(5), 1999, pp. 2358-2362
Reduced ultraviolet-induced carcinogenesis in mice with a functional disruption in B7-mediated costimulation
Authors: Beissert, S Bluestone, JA Mindt, I Voskort, M Metze, D Mehling, A Luger, TA Schwarz, T Grabbe, S
Citation: S. Beissert et al., Reduced ultraviolet-induced carcinogenesis in mice with a functional disruption in B7-mediated costimulation, J IMMUNOL, 163(12), 1999, pp. 6725-6731
Host B7-1 and B7-2 costimulatory molecules contribute to the eradication of B7-1-transfected P815 tumor cells via a CD8(+) T cell-dependent mechanism
Authors: La Motte, RN Sharpe, AH Bluestone, JA Mokyr, MB
Citation: Rn. La Motte et al., Host B7-1 and B7-2 costimulatory molecules contribute to the eradication of B7-1-transfected P815 tumor cells via a CD8(+) T cell-dependent mechanism, J IMMUNOL, 162(8), 1999, pp. 4817-4823
Regulation of cytotoxic T lymphocyte-associated molecule-4 by Src kinases
Authors: Chuang, E Lee, KM Robbins, MD Duerr, JM Alegre, ML Hambor, JE Neveu, MJ Bluestone, JA Thompson, CB
Citation: E. Chuang et al., Regulation of cytotoxic T lymphocyte-associated molecule-4 by Src kinases, J IMMUNOL, 162(3), 1999, pp. 1270-1277
Lymphoproliferative disorder in CTLA-4 knockout mice is characterized by CD28-regulated activation of th2 response
Authors: Khattri, R Auger, JA Griffin, MD Sharpe, AH Bluestone, JA
Citation: R. Khattri et al., Lymphoproliferative disorder in CTLA-4 knockout mice is characterized by CD28-regulated activation of th2 response, J IMMUNOL, 162(10), 1999, pp. 5784-5791
RIBP, a novel R1k/Txk- and Itk-binding adaptor protein that regulates T cell activation
Authors: Rajagopal, K Sommers, CL Decker, DC Mitchell, EO Korthauer, U Sperling, AI Kozak, CA Love, PE Bluestone, JA
Citation: K. Rajagopal et al., RIBP, a novel R1k/Txk- and Itk-binding adaptor protein that regulates T cell activation, J EXP MED, 190(11), 1999, pp. 1657-1668
Activation and peripheral expansion of murine T-cell receptor gamma delta intraepithelial lymphocytes
Authors: Guehler, SR Bluestone, JA Barrett, TA
Citation: Sr. Guehler et al., Activation and peripheral expansion of murine T-cell receptor gamma delta intraepithelial lymphocytes, GASTROENTY, 116(2), 1999, pp. 327-334
Phase I evaluation of humanized OKT3: Toxicity and immunomodulatory effects of hOKT3 gamma(4)
Authors: Richards, J Auger, J Peace, D Gale, D Michel, J Koons, A Haverty, T Zivin, R Jolliffe, L Bluestone, JA
Citation: J. Richards et al., Phase I evaluation of humanized OKT3: Toxicity and immunomodulatory effects of hOKT3 gamma(4), CANCER RES, 59(9), 1999, pp. 2096-2101
Molecular basis of T cell inactivation by CTLA-4
Authors: Lee, KM Chuang, E Griffin, M Khattri, R Hong, DK Zhang, WG Straus, D Samelson, LE Thompson, CB Bluestone, JA
Citation: Km. Lee et al., Molecular basis of T cell inactivation by CTLA-4, SCIENCE, 282(5397), 1998, pp. 2263-2266
Importance of B7-1-expressing host antigen-presenting cells for the eradication of B7-2 transfected P815 tumor cells
Authors: La Motte, RN Sharpe, AH Bluestone, JA Mokyr, MB
Citation: Rn. La Motte et al., Importance of B7-1-expressing host antigen-presenting cells for the eradication of B7-2 transfected P815 tumor cells, J IMMUNOL, 161(12), 1998, pp. 6552-6558
Realization of the therapeutic potential of CTLA-4 blockade in low-dose chemotherapy-treated tumor-bearing mice
Authors: Mokyr, MB Kalinichenko, T Gorelik, L Bluestone, JA
Citation: Mb. Mokyr et al., Realization of the therapeutic potential of CTLA-4 blockade in low-dose chemotherapy-treated tumor-bearing mice, CANCER RES, 58(23), 1998, pp. 5301-5304
Risultati: 1-25 | 26-42 |